Asia Pacific Semaglutide Market Size & Outlook, 2024-2035

The semaglutide market in Asia Pacific is expected to reach a projected revenue of US$ 10,055.5 million by 2035. A compound annual growth rate of 12.9% is expected of Asia Pacific semaglutide market from 2025 to 2035.
Revenue, 2024 (US$M)
$2,384.1
Forecast, 2035 (US$M)
$10,055.5
CAGR, 2025 - 2035
12.9%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific semaglutide market, 2018-2035 (US$M)

Asia Pacific semaglutide market, 2018-2035 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific semaglutide market highlights

  • The Asia Pacific semaglutide market generated a revenue of USD 2,384.1 million in 2024.
  • The market is expected to grow at a CAGR of 12.9% from 2025 to 2035.
  • In terms of segment, ozempic (semaglutide) was the largest revenue generating product in 2024.
  • Rybelsus (oral semaglutide) is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2025 to 2035.


Asia Pacific data book summary

Market revenue in 2024USD 2,384.1 million
Market revenue in 2035USD 10,055.5 million
Growth rate12.9% (CAGR from 2025 to 2035)
Largest segmentOzempic (semaglutide)
Fastest growing segmentRybelsus (oral semaglutide)
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2035
Quantitative unitsRevenue in USD million
Market segmentationOzempic (semaglutide), Wegovy (semaglutide), Rybelsus (oral semaglutide)


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 8.4% of the global semaglutide market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2035.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 10,055.5 million by 2035.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Semaglutide Market Companies

Name Profile # Employees HQ Website

Asia Pacific semaglutide market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to semaglutide market will help companies and investors design strategic landscapes.


Ozempic (semaglutide) was the largest segment with a revenue share of 68.32% in 2024. Horizon Databook has segmented the Asia Pacific semaglutide market based on ozempic (semaglutide), wegovy (semaglutide), rybelsus (oral semaglutide) covering the revenue growth of each sub-segment from 2018 to 2035.


The Asia-Pacific semaglutide market is witnessing rapid expansion, driven by rising obesity and diabetes prevalence, increasing healthcare investments, and regulatory approvals for GLP-1 therapies.

China, Japan, and India lead the market, supported by domestic pharmaceutical manufacturing and growing patient awareness. The region is experiencing increasing adoption of semaglutide in both hospital and retail pharmacy settings.

Reasons to subscribe to Asia Pacific semaglutide market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific semaglutide market databook

  • Our clientele includes a mix of semaglutide market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific semaglutide market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific semaglutide market from 2018 to 2035, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific semaglutide market size, by country, 2018-2035 (US$M)

Asia Pacific Semaglutide Market Outlook Share, 2024 & 2035 (US$M)

Asia Pacific semaglutide market size, by country, 2018-2035 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online